These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 31966599)
1. MiR-211 inhibits cell epithelial-mesenchymal transition by targeting MMP9 in gastric cancer. Wang XD; Wen FX; Liu BC; Song Y Int J Clin Exp Pathol; 2017; 10(7):7551-7558. PubMed ID: 31966599 [TBL] [Abstract][Full Text] [Related]
2. MIR-519d suppresses the gastric cancer epithelial-mesenchymal transition via Twist1 and inhibits Wnt/β-catenin signaling pathway. Yue H; Tang B; Zhao Y; Niu Y; Yin P; Yang W; Zhang Z; Yu P Am J Transl Res; 2017; 9(8):3654-3664. PubMed ID: 28861156 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-124 inhibits cell invasion and epithelial-mesenchymal transition by directly repressing Snail2 in gastric cancer. Li SL; Gao HL; Lv XK; Hei YR; Li PZ; Zhang JX; Lu N Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3389-3396. PubMed ID: 28829503 [TBL] [Abstract][Full Text] [Related]
4. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. Jin Y; Wang J; Han J; Luo D; Sun Z Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT. Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-217 suppressed epithelial-to-mesenchymal transition in gastric cancer metastasis through targeting PTPN14. Liu YP; Sun XH; Cao XL; Jiang WW; Wang XX; Zhang YF; Wang JL Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1759-1767. PubMed ID: 28485805 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail. Zuo QF; Cao LY; Yu T; Gong L; Wang LN; Zhao YL; Xiao B; Zou QM Cell Death Dis; 2015 Nov; 6(11):e2000. PubMed ID: 26610210 [TBL] [Abstract][Full Text] [Related]
8. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841 [TBL] [Abstract][Full Text] [Related]
9. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene. Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757 [TBL] [Abstract][Full Text] [Related]
10. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition. Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566 [TBL] [Abstract][Full Text] [Related]
11. MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting Li J; Li T; Lu Y; Shen G; Guo H; Wu J; Lei C; Du F; Zhou F; Zhao X; Nie Y; Fan D FASEB J; 2017 Sep; 31(9):3774-3786. PubMed ID: 28512191 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. Xu M; Qin S; Cao F; Ding S; Li M Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929 [TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis. Chen Z; Wu J; Huang W; Peng J; Ye J; Yang L; Yuan Y; Chen C; Zhang C; Cai S; He Y; Wu S; Song W Cell Physiol Biochem; 2018; 47(6):2432-2444. PubMed ID: 29991048 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-599 inhibits metastasis and epithelial-mesenchymal transition via targeting EIF5A2 in gastric cancer. Wang X; Jin Y; Zhang H; Huang X; Zhang Y; Zhu J Biomed Pharmacother; 2018 Jan; 97():473-480. PubMed ID: 29091897 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process. Tao Y; Yang S; Wu Y; Fang X; Wang Y; Song Y; Han T Oncotarget; 2017 Oct; 8(51):88870-88881. PubMed ID: 29179483 [TBL] [Abstract][Full Text] [Related]
16. The Wang DW; Su F; Zhang T; Yang TC; Wang HQ; Yang LJ; Zhou FF; Feng MH J Cancer; 2020; 11(17):5042-5055. PubMed ID: 32742452 [TBL] [Abstract][Full Text] [Related]
17. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer. Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228 [TBL] [Abstract][Full Text] [Related]
19. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition. Xie R; Wang X; Qi G; Wu Z; Wei R; Li P; Zhang D Tumour Biol; 2016 Sep; 37(9):12049-12059. PubMed ID: 27179963 [TBL] [Abstract][Full Text] [Related]
20. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer. Hu M; Zhao T; Liu J; Zou Z; Xu Q; Gong P; Guo H Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]